Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Unsealed Seroquel documents in US put AstraZeneca in the hot seat

This article was originally published in Scrip

Executive Summary

AstraZeneca has been embroiled in long-running product litigation surrounding its antipsychotic Seroquel (quetiapine fumarate), and it recently agreed to unseal a large batch of confidential internal documents produced in a federal court case in Florida – leading to unflattering articles in the US press based on the contents of e-mails and other communications.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC000520

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel